Hong Li

5.8k total citations
159 papers, 4.4k citations indexed

About

Hong Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hong Li has authored 159 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 41 papers in Oncology and 40 papers in Cancer Research. Recurrent topics in Hong Li's work include Epigenetics and DNA Methylation (31 papers), Cancer-related gene regulation (17 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Hong Li is often cited by papers focused on Epigenetics and DNA Methylation (31 papers), Cancer-related gene regulation (17 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Hong Li collaborates with scholars based in China, United States and Canada. Hong Li's co-authors include Chao Ge, Jinjun Li, Fangyu Zhao, Taoyang Chen, Zixing Shi, Min Lian, Jie Yin, Jinchen Fan, Ming Yao and Hua Tian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hong Li

151 papers receiving 4.3k citations

Peers

Hong Li
Comparison fields: 5 of 148
  • Molecular Biology 2.4k
  • Cancer Research 1.0k
  • Oncology 827
  • Pulmonary and Respiratory Medicine 414
  • Biomedical Engineering 391
Replace Aimin Li with:
Aimin Li China
Hao Liu China
Dongsheng Zhang China
Yong Mao China
Je‐Yoel Cho South Korea
Dan Zhao China
Jingxuan Yang China
Junhua Wu China
Chang Zou China
Lin Chen China
Aimin Li China View profile →
Citations per field, relative to Hong Li
Hong Li · 1×
Citations per year, relative to Hong Li
Hong Li · 1×

Countries citing papers authored by Hong Li

Since Specialization
Citations

This map shows the geographic impact of Hong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Li more than expected).

Fields of papers citing papers by Hong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Li. The network helps show where Hong Li may publish in the future.

Co-authorship network of co-authors of Hong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Li. A scholar is included among the top collaborators of Hong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Li. Hong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 2
3 2
4 2
5 1
6 4
7 0
8 0
9 12
10 26
11 5
12 10
13 76
14 39
15 55
16
The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinoma.
19
17 30
18 82
19 10
20 19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026